Jamieson Wellness Stock: Should You Buy the Dip?

I’m still bullish on Jamieson Wellness after its first-quarter earnings.

| More on:
supplements vitamins pills

Image source: Getty Images

Even if you don’t buy products from Jamieson Wellness (TSX:JWEL), you should still recognize the company’s distinctive green-capped vitamin bottles that you can find in almost any Canadian pharmacy. The Toronto company is a leading manufacturer, distributor, and marketer of natural health products and supplements. Shares of Jamieson have dropped about 17% year to date, and the stock recently moved into negative territory in the year-over-year period. Should you seek to buy the dip? Let’s dive in and find out.

Here’s why investors should seek exposure to this exciting sector

Late last year, I recommended that millennial investors target this stock. Jamieson’s long-term prospects are worth getting excited about.

When Jamison went public in 2017, leadership predicted the company would benefit from aging global demographics. Canadian seniors are expected to make up about one-quarter of the country’s total population by the middle of the next decade. This demographic is health-conscious — even more so in the wake of the COVID-19 pandemic.

The global dietary supplements market was worth an estimated US$155 billion to start 2022, according to research firm MarketsAndMarkets. The firm projects that this sector will deliver a CAGR of 7.3%, to US$220 billion, by 2027. That’s the kind of growth trajectory that should pique investors’ interest.

How does Jamieson Wellness look after its first-quarter results?

Total first-quarter revenue grew 5%, to $103 million. Jamieson Brands revenue rose 9% domestically and 14% on an international basis. That said, revenue declined in the Strategic Partners segment because of order timing and a big spike in revenues in the prior-year period.

Adjusted net earnings climbed 24% from the prior year, to $10.7 million, while adjusted diluted earnings per share jumped 23%, to $0.26.

Gross profit increased $4.1 million year-over-year, to $37.9 million. Moreover, adjusted EBITDA rose 13% to $20.9 million, and adjusted EBITDA margin was 20.2% compared with 18.9% in Q1 2021.

Should you buy Jamieson Wellness stock today?

Back in the summer of 2021, I picked Jamieson Wellness as my top stock for the rest of the year. The interest in natural health products and supplements has been bolstered by the COVID-19 pandemic, which stoked general health fears. Investors should expect to see more focus on the maintenance of good health in the months and years following this massive crisis.

Jamieson Wellness stock currently has a price-to-earnings ratio of 24. That puts this stock in favourable value territory compared with its industry peers. It also recently declared a quarterly dividend of $0.15 per share, which represents a modest 1.8% yield.

Potential Jamieson Wellness investors should be encouraged by its rock-solid Q1 2022 earnings. I’m looking to snatch up this stock myself sometime in the month of May.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Investing

dividends grow over time
Investing

Opinion: Your 2025 Investing Plan Should Include These Growth Stocks

Here are three top Canadian growth stocks long-term investors may want to consider right now.

Read more »

ETF chart stocks
Investing

These Are My 2 Favourite ETFs to Buy for 2025

iShares Core MSCI All Country World ex Canada Index ETF (TSX:XAW) and Vanguard All-Equity ETF Portfolio (TSX:VEQT) are strong options.

Read more »

calculate and analyze stock
Dividend Stocks

TFSA Investors: 3 Dividend Stocks to Consider Buying While They Are Down

These stocks offer attractive dividends right now.

Read more »

data analyze research
Dividend Stocks

Top Canadian Stocks to Buy Right Away With $2,000

These two Canadian stocks are the perfect pairing if you have $2,000 and you just want some easy, safe, awesome…

Read more »

money goes up and down in balance
Dividend Stocks

Take Full Advantage of Your TFSA With These 5 Dividend Stars

Choosing the right dividend stars for your TFSA can be tricky, especially if your goal is to maximize the balance…

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

The Best Canadian Dividend Stocks to Buy and Hold Forever in a TFSA

These three top dividend stocks are ideal for your TFSA due to their consistent dividend payouts and healthy yields.

Read more »

open vault at bank
Dividend Stocks

1 Magnificent TSX Dividend Stock, Down 10%, to Buy and Hold for a Lifetime

A recent dip makes this Big Bank stock an attractive buying opportunity.

Read more »

Canadian Dollars bills
Dividend Stocks

2 Incredibly Cheap Canadian Growth Stocks to Buy Before It’s Too Late

Buying cheap stocks needs patience and a long-term investment approach. Only then can they give you extraordinary returns.

Read more »